Accès ouvert
2026
article
OpenAlex
Nicholas J. Tursi, Colby J. Agostino, Jinwei Huang, Toshitha Kannan et autres
Vaccine approaches capable of eliciting enhanced germinal center (GC) responses would result in improved protective humoral immunity against infectious diseases. Here, we investigate whether a cytokine can be scaffolded onto a self-assembling nanoparticle immunogen to enhance antigen-specific GC responses and B cell …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Michaela Helble, Xizhou Zhu, Pratik Sanjivkumar Bhojnagarwala, Kevin Liaw et autres
Oncogenic forms of HPV account for 4.5% of the global cancer burden worldwide. This includes cervical, vaginal, vulvar, penile, and anal cancers, as well as head and neck cancers. As such, there is an urgent need to develop effective therapeutic vaccines to …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Michaela Helble, Jacqueline D. Chu, Abigail Rose Trachtman, Alana Huynh et autres
Monoclonal antibodies are an important class of biologics with over 160 Food and Drug Administration/European Union-approved drugs. A significant bottleneck to global accessibility of recombinant monoclonal antibodies stems from complexities related to their production, storage, and distribution. Recently, gene-encoded approaches such as …
us
(code pays fourni par la source)
2024
conference-abstract
OpenAlex
Nicholas J. Tursi, Toshitha Kannan, Jennifer A. Londregan, Katlyn Lederer et autres
Abstract An alluring strategy for improving protective humoral immunity against infectious diseases would be to directly target the germinal center (GC). Robust GC responses are associated with high titer and high affinity antibody responses. Despite advances in formulation strategies and vaccine design, …
us
(code pays fourni par la source)
2024
dissertation
OpenAlex
Michaela Helble
New nucleic-acid delivery technologies, such as DNA delivery, have recently come to the forefront of scientific advances. As this field is relatively new, the parameters and mechanisms that guide successful and potent DNA immunotherapies still require further elucidation. DNA delivery of monoclonal …
Accès ouvert
2023
article
OpenAlex
Nicholas J. Tursi, Ziyang Xu, Michaela Helble, Susanne N. Walker et autres
Cancer immunotherapy has demonstrated great promise with several checkpoint inhibitors being approved as the first-line therapy for some types of cancer, and new engineered cytokines such as Neo2/15 now being evaluated in many studies. In this work, we designed antibody-cytokine chimera (ACC) …
us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Susanne N. Walker, Neethu Chokkalingam, Emma L. Reuschel, Mansi Purwar et autres
(SARS-CoV-2) has caused a global pandemic of COVID-19, resulting in cases of mild to severe respiratory distress and significant mortality. The global outbreak of this novel coronavirus has now infected >20 million people worldwide, with >5 million cases in the United States …
us
(code pays fourni par la source)
Accès ouvert
2015
conference-paper
OpenAlex
Graham Barry Bartlett Scott, Ian Kowalok, Michaela Helble, Scott J. Lehman et autres